Breast Cancer Update artwork

Breast Cancer Update

477 episodes - English - Latest episode: 30 days ago - ★★★★ - 57 ratings

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Science Health & Fitness Medicine breastcancer breast cancer oncology
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

BCUTT2 2007 | Emerging Data and Clinical Trials Evaluating Bevacizumab

November 28, 2007 20:02 - 21 minutes - 12.6 MB

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Emerging Data and Clinical Trials Evaluating Bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCUTT2 2007 | Treatment Considerations for Triple-Negative Breast Cancer

November 28, 2007 20:01 - 7 minutes - 4.3 MB

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Treatment Considerations for Triple-Negative Breast Cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCUTT2 2007 | Long-Term Adjuvant Endocrine Therapy

November 28, 2007 20:00 - 43 minutes - 24.8 MB

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Long-Term Adjuvant Endocrine Therapy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCUTT2 2007 | Advancing Clinical Research

November 28, 2007 19:59 - 17 minutes - 9.88 MB

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Advancing Clinical Research. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU6 2007 | Interview with George W Sledge Jr, MD

November 14, 2007 22:33 - 1 hour - 37.4 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU6 2007 | Interview with William J Gradishar, MD

November 14, 2007 22:33 - 50 minutes - 29.1 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU6 2007 | Interview with Lee S Schwartzberg, MD

November 14, 2007 22:32 - 37 minutes - 21.2 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU6 2007 | Interview with Tumor Panel with Drs Burstein and O’Shaughnessy, MD

November 14, 2007 22:31 - 41 minutes - 23.6 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Tumor Panel with Dr Harold Burstein and Dr Joyce O’Shaughnessy conducted by Neil Love, MD. Produced by Research To Practice.

BCU5 2007 | Interview with Sharon Giordano, MD, MPH 01

August 09, 2007 18:29 - 37 minutes - 21.5 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU5 2007 | Interview with Rowan T Chlebowski, MD, PhD 02

August 09, 2007 18:28 - 49 minutes - 28.5 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU5 2007 | Interview with Tumor Panel Case Discussion 03

August 09, 2007 18:25 - 1 hour - 36.3 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU5 2007 | Interview with Jack Cuzick, PhD 04

August 09, 2007 18:22 - 33 minutes - 18.9 MB

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

BCU 4 | 07 - Perez

May 29, 2007 21:16 - 46 minutes - 26.6 MB

Interview with Edith A Perez, MD

BCU 4 | 07 - Swain

May 29, 2007 21:15 - 41 minutes - 24 MB

Interview with Sandra M Swain, MD

BCU 4 | 07 - Pritchard

May 29, 2007 21:15 - 43 minutes - 24.7 MB

Interview with Kathleen I Pritchard, MD

BCU 4 | 07 - Piccart-Gebhart

May 29, 2007 19:57 - 46 minutes - 26.5 MB

Interview with Martine J Piccart-Gebhart, MD, PhD

BCU 4 | 07 - O’Regan

May 29, 2007 19:56 - 37 minutes - 21.5 MB

Interview with Ruth O’Regan, MD

BCU Think Tank 1 | 07 - Adjuvant Endocrine Therapy

May 14, 2007 21:49 - 32 minutes - 14.9 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”

BCU Think Tank 1 | 07 - HER2-Positive Disease

May 14, 2007 21:16 - 53 minutes - 30.5 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”

BCU Think Tank 1 | 07 - Adjuvant Chemotherapy

May 14, 2007 21:15 - 50 minutes - 29.1 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”

BCU Think Tank 1 | 07 - Systemic Therapy of Metastatic Disease

May 14, 2007 21:13 - 33 minutes - 19.3 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank"

BCU Think Tank 1 | 07 - Metastatic Endocrine Therapy

May 14, 2007 21:13 - 8 minutes - 4.9 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”

BCU Think Tank 1 | 07 - Lifestyle Modifications

May 14, 2007 20:43 - 11 minutes - 6.55 MB

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”

BCU 3 | 07 - Winer

May 03, 2007 19:41 - 49 minutes - 28.1 MB

Interview with Eric P Winer, MD

BCU 3 | 07 - Buzdar

May 03, 2007 19:40 - 46 minutes - 26.7 MB

Interview with Aman U Buzdar, MD

BCU 3 | 07 - Tumor Panel

May 03, 2007 19:39 - 55 minutes - 31.7 MB

Tumor Panel Case Discussion: Brian Leyland-Jones, MD, PhD and Mark D Pegram, MD

BCU 3 | 07 - Howell

May 03, 2007 19:34 - 31 minutes - 18.2 MB

Interview with Anthony Howell, MD

BCU 3 | 07 - Paik

May 03, 2007 19:32 - 33 minutes - 19.1 MB

Interview with Soonmyung Paik, MD

BCU 2 | 07 - Holmes

March 22, 2007 19:15 - 46 minutes - 26.4 MB

Interview with Frankie Ann Holmes, MD

BCU 2 | 07 - Mamounas

March 22, 2007 19:13 - 36 minutes - 21.2 MB

Interview with Eleftherios P Mamounas, MD, MPH

BCU 2 | 07 - Seidman

March 22, 2007 18:59 - 37 minutes - 21.4 MB

Interview with Andrew D Seidman, MD

BCU 2 | 07 - Lipton

March 22, 2007 18:58 - 48 minutes - 27.8 MB

Interview with Allan Lipton, MD

BCU 2 | 07 - Marx

March 22, 2007 18:57 - 35 minutes - 20.6 MB

Interview with Robert E Marx, DDS

SABCS Spin-Off | 06 - Burstein

March 16, 2007 21:01 - 6 minutes - 3.81 MB

Most patients with ER-positive, HER2-negative, node-negative breast cancer should be presented with the option of participating in the TAILORx trial and of having the Oncotype DX assay performed outside of a trial.

SABCS Spin-Off | 06 - Buzdar

March 16, 2007 20:58 - 13 minutes - 8.71 MB

For postmenopausal women with ER-positive, metastatic disease, tamoxifen, an aromatase inhibitor or fulvestrant are essentially equivalent choices.

SABCS Spin-Off | 06 - Hudis

March 16, 2007 20:55 - 15 minutes - 8.71 MB

Outside a protocol setting, dose-dense AC ->paclitaxel, administered every two weeks with growth factors, with trastuzumab during and following the paclitaxel, provides the best potential risk/benefit profile for women with HER2-positive, node-positive disease.

SABCS Spin-Off | 06 - Dixon

March 16, 2007 20:53 - 12 minutes - 7.09 MB

Neoadjuvant therapy with an aromatase inhibitor provides the best potential risk/benefit profile for postmenopausal women with HER2-negative, strongly ER-positive and PR-positive disease.

SABCS Spin-Off | 06 - Vogel

March 16, 2007 20:48 - 7 minutes - 4.14 MB

Outside a protocol setting, carboplatin/docetaxel/trastuzumab followed by trastuzumab for a total duration of one year provides the best potential risk/benefit profile for elderly patients with ER-negative, PR-negative, HER2-positive, multiple node-positive breast cancer with a prior cardiac history.

SABCS Spin-Off | 06 - Mackey

March 16, 2007 20:40 - 9 minutes - 5.6 MB

Outside a protocol setting, a combination of endocrine therapy and trastuzumab provides the best potential risk/benefit profile for women with ER-positive, HER2-positive metastatic disease.

SABCS Spin-Off | 06 - Tripathy

March 16, 2007 20:40 - 4 minutes - 2.59 MB

Outside a protocol setting, the combination of lapatinib and capecitabine provides the best potential risk/benefit profile for women with ER-negative, PR-negative, HER2-positive, node-positive disease with cancer recurrence after AC->TH.

BCU 1 | 07 - Norton

February 02, 2007 15:08 - 37 minutes - 21.7 MB

Interview with Larry Norton, MD

BCU 1 | 07 - Muss

February 02, 2007 15:07 - 46 minutes - 26.7 MB

Interview with Hyman B Muss, MD

BCU 1 | 07 - Sparano

February 02, 2007 15:06 - 55 minutes - 32 MB

Interview with Joseph A Sparano, MD

BCU 1 | 07 - Roundtable Discussion

February 02, 2007 15:02 - 1 hour - 34.9 MB

Roundtable Discussion

BCU 8 | 06 - Burstein

January 05, 2007 15:47 - 46 minutes - 26.4 MB

Interview with Harold J Burstein, MD, PhD

BCU 8 | 06 - Ravdin

January 05, 2007 15:46 - 29 minutes - 17.1 MB

Interview with Peter M Ravdin, MD, PhD

BCU 8 | 06 - Livingston

January 05, 2007 15:45 - 36 minutes - 21.2 MB

Interview with Robert Livingston, MD

BCU 8 | 06 - Bear

January 05, 2007 15:44 - 39 minutes - 22.5 MB

Interview with Harry D Bear, MD, PhD

BCU 8 | 06 - Carey & Chang

January 05, 2007 15:43 - 58 minutes - 33.7 MB

Interview with Lisa Carey, MD and Jenny C Chang, MD

BCU 7 | 06 - Pegram

November 29, 2006 22:57 - 1 hour - 43.3 MB

Interview with Mark D Pegram, MD